Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study (Q39452960)

12 September 2017

Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study (English)

1 reference

12 September 2017

1 reference

myocardial infarction

1 reference

Shandling AH

1

1 reference

12 September 2017

Ellestad MH

2

1 reference

12 September 2017

Hart GB

3

1 reference

12 September 2017

Crump R

4

1 reference

12 September 2017

Marlow D

5

1 reference

12 September 2017

Van Natta B

6

1 reference

12 September 2017

Messenger JC

7

1 reference

12 September 2017

Strauss M

8

1 reference

12 September 2017

Stavitsky Y

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

12 September 2017

American Heart Journal

1 reference

12 September 2017

134

1 reference

12 September 2017

544-550

1 reference

12 September 2017

3

1 reference

Metabolic effects of hyperbaric oxygen in postischemic muscle

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Protective effect of hyperbaric oxygen for the temporary ischaemic myocardium. Macroscopic and histological data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Hyperbaric oxygenation in the treatment of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Efforts to Limit the Size of Myocardial Infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Haemodynamic and metabolic effects of hyperbaric oxygen in myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Severe acute myocardial infarction treated with hyperbaric oxygen. Report on forty patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Clot-selective coronary thrombolysis with tissue-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

THE EFFECTS OF ALTERED ARTERIAL TENSIONS OF CARBON DIOXIDE AND OXYGEN ON CEREBRAL BLOOD FLOW AND CEREBRAL OXYGEN CONSUMPTION OF NORMAL YOUNG MEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

HIGH OXYGEN PRESSURE AND THE RETINAL BLOOD-VESSELS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Retinal Vascular Response to Hyperbaric Oxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Cardiac oxygen metabolism and control of the coronary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Alteration of coronary blood flow in the dog by inhalation of 100 per cent oxygen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Response of regional circulations to hyperoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Effects of high oxygen on coronary flor and heart force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Hyperbaric oxygenation: influence on coronary blood flow and oxygen delivery to the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium").

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Oxygen-mediated myocardial damage during ischameia and reperfusion: Role of the cellular defences against oxygen toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Does reperfusion injury exist in humans?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

The stunned myocardium: prolonged, postischemic ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

Treatment of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970093-0

10.1016/S0002-8703(97)70093-0

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference